Search - tctmd.com

Displaying 241 - 260 of 316

Sort: Relevancy | Date

Presentation THT 2026

Overview of Gene Therapies for Specific Cardiomyopathies

Presenter: Barry Greenberg

March 02, 2026

Presentation THT 2026

Not Quite PGD: Classification of Abnormal Hemodynamic Phenotypes after Heart Transplant

Presenter: Jordan Liebman

March 02, 2026

Presentation THT 2026

The Emperor Rises: First In Vitro and In Vivo Evaluation of SynCardia’s Electromechanical Total Artificial Heart

Presenter: Andre Simon

March 02, 2026

Presentation THT 2026

No: Only Select Patients Should Receive a Remote Monitoring Device

Presenter: JoAnn Lindenfeld

March 02, 2026

Presentation THT 2026

Yes: Most Patients Discharged from a HF Hospitalization Should Receive a Remote Monitoring Device

Presenter: Nir Uriel

March 02, 2026

Presentation THT 2026

NO: The Evidence is Not Strong Enough to Support TEER in Moderate MR in HF

Presenter: Gregg W. Stone

March 02, 2026

Presentation THT 2026

Smart Adaptive LVAD to Tailor its Operation to Physiological State during Day

Presenter: Jonathan Grinstein

March 02, 2026

Presentation THT 2026

Implications for IABP Use in HF Shock With the New Allocation System

Presenter: Ulrich P. Jorde

March 02, 2026

Presentation THT 2026

YES: TEER is Totally Appropriate for Patients With Moderate MR if HF

Presenter: Stefan Anker

March 02, 2026

Presentation THT 2026

Self-Management of Pressures to Reduce HF Hospitalizations

Presenter: Anique Ducharme

March 02, 2026

Presentation THT 2026

Development and Validation of a Model to Predict Risk of Dialysis Following Ventricular Assist Device Placement

Presenter: Wendy McCallum

March 02, 2026

Presentation THT 2026

Does the Future Rest on Multiparametric Devices?

Presenter: Gerin R. Stevens

March 02, 2026

Presentation THT 2026

Left Ventricular Assist Devices And Cachexia: Improved Outcomes With Nutritional Consult Intervention

Presenter: Manthan Patel

March 02, 2026

Presentation THT 2026

Implications for IABP Use in Shock: Lessons Learned From the Cardiogenic Shock Registry

Presenter: Arthur Reshad Garan

March 02, 2026

Presentation THT 2026

Wearable Devices for Outpatient Monitoring — Where are we Today?

Presenter: Gabriel Sayer

March 02, 2026

Presentation THT 2026

Comparing the Strategy of LVAD versus Heart Transplantation Listing by Age in National US Data: Informing Patient Centered Decision Making

Presenter: Thomas Cascino

March 02, 2026

Presentation THT 2026

Antagonist: Deep Phenotyping and Phenomapping Has Been and Will Continue to Be A Mirage in Understanding the Mechanisms and Tailoring Treatment for HFpEF.

Presenter: Milton Packer

March 02, 2026

Presentation THT 2026

Implantable Pressure-Base Remote Monitoring Devices: What are the Differences?

Presenter: Liviu Klein

March 02, 2026

Presentation THT 2026

Clinical Viewpoint: Fallout from the IABP Shock II and Alt-Shock Studies

Presenter: Joyce Wanglee Wald

March 02, 2026

Presentation THT 2026

Protagonist: HFpEF is Highly Heterogeneous, Requiring a Multimodal Precision Medicine Approach for True Progress.

Presenter: Sanjiv J. Shah

March 02, 2026

Advertisement

Overview of Gene Therapies for Specific Cardiomyopathies

Not Quite PGD: Classification of Abnormal Hemodynamic Phenotypes after Heart Transplant

The Emperor Rises: First In Vitro and In Vivo Evaluation of SynCardia’s Electromechanical Total Artificial Heart

No: Only Select Patients Should Receive a Remote Monitoring Device

Yes: Most Patients Discharged from a HF Hospitalization Should Receive a Remote Monitoring Device

NO: The Evidence is Not Strong Enough to Support TEER in Moderate MR in HF

Smart Adaptive LVAD to Tailor its Operation to Physiological State during Day

Implications for IABP Use in HF Shock With the New Allocation System

YES: TEER is Totally Appropriate for Patients With Moderate MR if HF

Self-Management of Pressures to Reduce HF Hospitalizations

Development and Validation of a Model to Predict Risk of Dialysis Following Ventricular Assist Device Placement

Does the Future Rest on Multiparametric Devices?

Left Ventricular Assist Devices And Cachexia: Improved Outcomes With Nutritional Consult Intervention

Implications for IABP Use in Shock: Lessons Learned From the Cardiogenic Shock Registry

Wearable Devices for Outpatient Monitoring — Where are we Today?

Comparing the Strategy of LVAD versus Heart Transplantation Listing by Age in National US Data: Informing Patient Centered Decision Making

Antagonist: Deep Phenotyping and Phenomapping Has Been and Will Continue to Be A Mirage in Understanding the Mechanisms and Tailoring Treatment for HFpEF.

Implantable Pressure-Base Remote Monitoring Devices: What are the Differences?

Clinical Viewpoint: Fallout from the IABP Shock II and Alt-Shock Studies

Protagonist: HFpEF is Highly Heterogeneous, Requiring a Multimodal Precision Medicine Approach for True Progress.

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content